ScholarIQanswers from OpenAlex

Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect?

PaperCitations, authors & open-access status

Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? have?

ScholarIQcitation count

Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? published?

ScholarIQyear

Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? has 2011 year in the ScholarIQ index.

What is the open-access status of Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect??

ScholarIQoa status

Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? has closed oa status in the ScholarIQ index.

What is the DOI of Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect??

ScholarIQdoi

The DOI for Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? is on the source record.

What is the PMID of Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect??

ScholarIQpmid

The PMID for Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? is on the source record.

What is the OpenAlex record for Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect??

ScholarIQopenalex

The OpenAlex for Low‐dose UVA <sub>1</sub> phototherapy for scleroderma: what benefit can we expect? is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial